Search

Search Constraints

You searched for: Author/Creator Amling, Christopher L.

Search Results

11. Factors predicting skeletal‐related events in patients with bone metastatic castration‐resistant prostate cancer. Issue 9 (27th December 2016)

12. Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation Therapy. Issue 7 (6th March 2017)

13. Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy. Issue 17 (1st May 2019)

14. Is clinical stage T2c prostate cancer an intermediate‐ or high‐risk disease?. Issue 9 (9th December 2014)

15. Is clinical stage T2c prostate cancer an intermediate‐ or high‐risk disease?. Issue 9 (9th December 2014)

16. Is computed tomography a necessary part of a metastatic evaluation for castration‐resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database. Issue 2 (20th October 2015)

17. Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH. Issue 16 (10th October 2017)

18. Number of Unfavorable Intermediate‐Risk Factors Predicts Pathologic Upstaging and Prostate Cancer‐Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database. Issue 2 (29th September 2016)

19. Obese patients with castration‐resistant prostate cancer may be at a lower risk of all‐cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. (10th April 2018)

20. Obesity, race, and long‐term prostate cancer outcomes. Issue 16 (4th June 2020)